These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10161397)

  • 1. FDA & clinical software vendors: a line in the sand?
    Schneider P
    Healthc Inform; 1996 Jun; 13(6):100-2, 104, 106. PubMed ID: 10161397
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA software policy and regulation of medical device software.
    Crumpler ES; Rudolph H
    Food Drug Law J; 1997; 52(4):511-6. PubMed ID: 10346676
    [No Abstract]   [Full Text] [Related]  

  • 3. AIDS and the blood supply: an analysis of law, regulation, and public policy.
    Salbu SR
    Wash Univ Law Q; 1996; 74(4):913-80. PubMed ID: 16273697
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA final guidance on software validation.
    Donawa M
    Med Device Technol; 2002 Apr; 13(3):20-4. PubMed ID: 12030100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboses in the arteries of commerce: inefficiency in blood bank regulation.
    Biggs SM; Liang BA
    J Health Hosp Law; 1992 Sep; 25(9):265-8, 288. PubMed ID: 10123301
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA regulation of clinical software: what does this mean for the industry?
    Trimbach J
    Healthc Inform; 1995 Nov; 12(11):10, 12, 14. PubMed ID: 10152714
    [No Abstract]   [Full Text] [Related]  

  • 7. A foot in the door. Interview by Carolyn Dunbar.
    Simons D
    Comput Healthc; 1991 Sep; 12(9):57-8. PubMed ID: 10112906
    [No Abstract]   [Full Text] [Related]  

  • 8. Impending FDA regulations of healthcare software. First stop: blood banking. Interview by Bill W. Childs.
    Marrazzo J
    US Healthc; 1988 Nov; 5(11):17-8. PubMed ID: 10291018
    [No Abstract]   [Full Text] [Related]  

  • 9. Food and Drug Administration regulation of blood bank software: the new regulatory landscape for blood establishments and their vendors.
    Weeda DF; O'Flaherty NF
    Transfusion; 1998 Jan; 38(1):86-9. PubMed ID: 9482400
    [No Abstract]   [Full Text] [Related]  

  • 10. New FDA software proposals: effect on nuclear medicine?
    Harby K
    J Nucl Med; 1988 May; 29(5):588-9, 591. PubMed ID: 3373301
    [No Abstract]   [Full Text] [Related]  

  • 11. Industry responds to FDA.
    Cosham RH
    Comput Healthc; 1988 Mar; 9(3):63, 65. PubMed ID: 10285979
    [No Abstract]   [Full Text] [Related]  

  • 12. Misbegotten preemptions.
    Kennedy D
    Science; 2008 May; 320(5876):585. PubMed ID: 18451268
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA regulation of telemedicine devices.
    Reichertz PS; Halpern NJ
    Food Drug Law J; 1997; 52(4):517-23. PubMed ID: 10346677
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of medical software by the Food and Drug Administration.
    Jorgens J; Schneider RH
    Softw Healthc; 1985; 3(2):27-9. PubMed ID: 10278374
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA announces expanded safeguards against mad cow disease.
    J Environ Health; 2004 May; 66(9):29. PubMed ID: 15137347
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA seeks tighter rules on blood donors.
    Kaye D
    Clin Infect Dis; 2001 Oct; 33(8):i. PubMed ID: 11669068
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulating blood manufacturing software: report of a conference.
    Macpherson J; Kochman S; McCullough J
    Transfusion; 2009 Nov; 49(11):2490-4. PubMed ID: 19903297
    [No Abstract]   [Full Text] [Related]  

  • 18. Exemption of certain transfusion services and clinical laboratories from registration: Food and Drug Administration. Final rule.
    Fed Regist; 1980 Dec; 45(251 Pt 1):85727-30. PubMed ID: 10298064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA regulation of biomedical software.
    Gamerman GE
    Proc Annu Symp Comput Appl Med Care; 1992; ():745-9. PubMed ID: 1482971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA considering new rules that may clamp down on early showings of works in progress.
    Wagner M
    Mod Healthc; 1992 Aug; 22(32):34. PubMed ID: 10119785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.